Alan Jonas
Psychiatry · Baltimore, MDNPI 1467552521
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $14,950 of the $19,957 with a category attached, or 74.9%. Johnson & Johnson accounts for 92.4% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2019 at $13,567 and has fallen 99.4% since, to $79 in 2024. Among psychiatry clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 130 payments — averaging $153.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$18K
- Corium, LLC$424
- AbbVie$212
- Takeda Pharmaceuticals U.S.A., Inc.$128
- Amgen$125
- Neos Therapeutics, LP$109
- plus $528 from 14 others
Across 104 payments — averaging $10,145 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$495K
- Eli Lilly$277K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$224K
- Alkermes, Inc.$34K
- Sage Therapeutics, LLC$14K
- Takeda Pharmaceuticals U.S.A., Inc.$10K
- plus $2K from 2 others
What the payments were for
- Speaking & faculty fees$14,95075%
- Travel & lodging$2,80714%
- Food & beverage$2,15311%
- Education$470%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 39 | $18,432 |
| Corium, LLC | 19 | $424 |
| AbbVie(2 entities) | 21 | $212 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $128 |
| Amgen | 1 | $125 |
| Neos Therapeutics, LP | 11 | $109 |
| Otsuka America Pharmaceutical, Inc. | 5 | $83 |
| Bausch Health US, LLC | 4 | $82 |
| Almatica Pharma LLC | 4 | $74 |
| Vanda Pharmaceuticals Inc. | 4 | $70 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $63 |
| Eisai Inc. | 1 | $25 |
| Ironshore Pharmaceuticals Inc. | 2 | $24 |
| Tris Pharma Inc | 1 | $19 |
| Lundbeck LLC | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Adlon Therapeutics L.p. | 1 | $14 |
| Jazz Pharmaceuticals Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
| Shire North American Group Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$19,957 in reported general payments places this provider in the 95th percentile of 851 psychiatry providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrintellixVortioxetine Hydrobromide | 11 | $15,264 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 21 | $871 |
| Clonazepam | 74 | $602 |
| Bupropion XlBupropion Hcl | 18 | $569 |
| Fluoxetine Hcl | 21 | $544 |
| Clozapine | 11 | $451 |
| Mirtazapine | 13 | $437 |
| Risperidone | 11 | $360 |
| Benztropine Mesylate | 11 | $295 |
| Escitalopram Oxalate | 21 | $241 |
| Lorazepam | 30 | $189 |
| Lamotrigine | 13 | $186 |
| Trazodone Hcl | 13 | $182 |
| Sertraline Hcl | 12 | $155 |
| Zolpidem Tartrate ErZolpidem Tartrate | 13 | $122 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $128 | $15,26411 claims |
| Almatica Pharma LLCSertraline Hcl | $74 | $15512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 851 psychiatry providers in Maryland.
Other psychiatry in Baltimore
- John VaethBaltimore$2.1M
- Scott AaronsonBaltimore$334K
- Robert LehmanBaltimore$140K
- Karen AndersonBaltimore$117K
- Orlando DavisBaltimore$104K
- Akira SawaBaltimore$69K
- Paul RosenbergBaltimore$66K
- Adam KaplinBaltimore$62K
- Marc FishmanBaltimore$59K
- David NeubauerBaltimore$59K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.